[1] National Health Commission of the People's Republic of China, Clinical management of human infection with novel coronavirus(2019-nCoV)(Interim guidance v5,revised version)[EB/OL]. [2020-02-08]. http://www. nhc. gov. cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a. shtml
[2] LI X,ZAI J,WANG X,et al. Potential of large 'first generation' human-to-human transmission of 2019-nCoV[J]. J Med Virol. doi:10. 1002/jmv. 25693. [published online ahead of print,2020 Jan 30].
[3] ROTHE C, SCHUNK M, SOTHMANN P, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in German[J]. N Engl J Med, 2020. doi:10. 1056/NEJMc2001468. [published online ahead of print, 2020 Jan 30].
[4] LU R, ZHAO X, LI J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus:implications for virus origins and receptor binding [J]. Lancet, 2020. doi:10. 1016/S0140-6736(20)30251-8. [published online ahead of print, 2020 Jan 30]
[5] ZHOU P, YANG X L, WANG X G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020. https://doi. org/10. 1038/s41586-020-2012-7.
[6] HUANG C, WANG Y, LI X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. [J]. The Lancet. https://doi. org/10. 1016/ S0140-6736(20)30183-5. [Published online January 24, 2020]
[7] CHEN N, ZHOU M, DONG X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China:a descriptive study[J]. Lancet, 2020. https://doi. org/10. 1016/S0140-6736(20)30211-7.
[8] KOREN G, KING S, KNOWLES S, et al. Ribavirin in the treatment of SARS: A new trick for an old drug?[J]. CMAJ, 2003, 168(10):1289-1292.
[9] MOMATTIN H, MOHAMMED K, ZUMLA A, et al. Therapeutic options for Middle East Respiratory Syndrome Coronavirus(MERS-CoV)-possible lessons from a systematic review of SARS-CoV therapy[J]. Int J Infect Dis, 2013, 17:e792-789.
[10] World Health Organization. Clinical management of severe acute respiratory infection when Novel coronavirus(2019-nCoV)infection is suspected:Interim Guidance. [EB/OL]. [2020-01-12]. https://www. who. int/docs/default-source/coronaviruse/clinical-management-of-novel-cov. pdf?sfvrsn=bc7da517_2.
[11] Ch. P(2015). Vol Ⅰ(中国药典2015年版, 一部)[S]. 2015.
[12] LIU S S, XIE Y M. Literature Analysis of 101 Cases of Adverse Reactions Induced by HuoxiangzhengqiLiquid[J]. Chin J Pharmacov(中国药物警戒), 2017, 14(5):317-320.
[13] HUANG L, WANG Y N, WU S Y. Research Progress of Pharmacological Effects of Traditional Chinese Medicines Ephedrae[J]. Chin Foreign Med Treatment(中外医疗), 2018, 37(7):195-198.
[14] BAI Y, TAN H. A Case of Gastrointestinal Adverse Reaction Induced by LianhuaqingwenCapsules[J]. China Licensed Pharm(中国执业药师), 2014, (1):47-48.
[15] PENG L L, LI L, SHEN L, et al. Literature Analysis of Clinical Application and Adverse Drug Reaction/Event of LianhuaQingwenCapsule[J]. Chin J Pharmacov(中国药物警戒), 2015, 12(12):753-755+759.
[16] HONG X F, LIN Q, CHEN X X, et al. Logistic Regression Analysis on Influential Factors of Xuebijing Injection - induced Adverse Drug Reactions[J]. Eval Anal Drug-Use Hosp China(中国医院用药评价与分析), 2013, 13(10):941-943.
[17] HE D J, QU Y H. Analysis of 60 Cases of Adverse Drug Reactions Caused by ShenfuInjection[J]. Chin J Pharmacov(中国药物警戒), 2014, 11(3):160-162.
[18] Xiehe Hospital, Huazhong University of science and technology. Recommendations for the management of pregnancy women infected with novel coronavirus. [EB/OL]. [2020-01-27]. Published online.
[19] WANG X Y, WU J, LU X H, et al. Recommendations for management of novel coronavirus(2019-nCoV)infected maternal women in Henan Province China [J]. J Zhengzhou Univ(Med Sci)(郑州大学学报(医学版)), 2020, 55(2):1-3.
[20] MAXWELL C, MCGEER A, TAI K F Y, et al. No. 225-Management Guidelines for Obstetric Patients and Neonates Born to Mothers with Suspected or Probable Severe Acute Respiratory Syndrome(SARS)[J]. J Obste Gynaecol Can, 2017. 39(8):e130-e137.
[21] ZHAO D C, JIN R M, LIU Z S, et al. Recommendation for the diagnosis and treatment of novel coronavirus infection in children in Hubei(Interim version 1)[J]. Chin J Contemp Pediatr(中国当代儿科杂志), 2020. 22(2):96-99.
[22] Evidence-Based Medicine Chapter Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team, China International Exchange and Promotive Association for Medical and Health Care. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus(2019-nCoV)infected pneumonia(Standard version)[J]. Med J Chin PLA(解放军医学杂志), 2020, 45(1):1-20.
[23] BAIU I, SPAIN D A. Enteral Nutrition[J]. JAMA, 2019, 321(20):2040. doi:10. 1001/jama. 2019. 4407.
[24] BAIU I, SPAIN D A. Parenteral Nutrition[J]. JAMA, 2019, 321(21):2142. doi:10. 1001/jama. 2019. 4410.
[25] MCCLAVE S M, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient:Society of Critical Care Medicine(SCCM)and American Society for Parenteral and Enteral Nutrition(A. S. P. E. N. ). [J]. PEN J Parenter Enteral Nutr, 2016, 40(2):159–211.
[26] MUELLER C M. The ASPEN Adult Nutrition Support Core Curriculum, 3rd Ed[M]. Silver Spring, MD:ASPEN; 2017.
[27] Peking University Third Hospital. Emergency plan for management of 2019 novel coronavirus-infected pneumonia for department of pharmacy [EB/OL]. [2020-02-07].
[28] National Health Commission of the People's Republic of China. Technical guidelines for prevention and control of novel coronavirus(2019-nCoV)infection in medical Institutions(guidance v1). [EB/OL]. [2020-01-23]. http://www. nhc. gov. cn/xcs/yqfkdt/202001/b91fdab7c304431eb082d67847d27e14. shtml.
[29] Chinese Association for Mental Health. Guidance for public psychological self-help and grooming during 2019-nCoV induced pneumonitis [M]. Beijing:People's Medical Publishing House. 2020.
[30] National Health Commission of the People's Republic of China. Principles for psychological crisis intervention during the outbreak of human infection with 2019-nCoV. [EB/OL]. [2020-01-26] http://www. nhc. gov. cn/jkj/s3577/202001/6adc08b966594253b2b791be5c3b9467. shtml
[31] National Health Commission of the People's Republic of China. Guidance for the use of common medical protective equipment in the prevention and control of novel coronavirus(2019-nCoV)-infected pneumonia(Interim version). [EB/OL]. [2020-01-26]. http://www. nhc. gov. cn/xcs/zhengcwj/202001/e71c5de925a64eafbe1ce790debab5c6. shtml
[32] LI S Y, HUANG W Z, LIAO X L, et al. Disease control of 2019 novel coronavirus infection in hospital: West China urgentrecommendation [J]. Chin J Evid Base Med(中国循证医学杂志), 2020, 20(2):125-133.
[33] Ministry of Health of the People's Republic of China. Technical specifications for disinfection of medical institutions[M]. Beijing:Standard Press of China. 2014.
[34] RABENAU H F, CINATL J, MORGENSTERN B, et al. Stability and inactivation of SARS coronavirus[J]. Med Microbiol Immunol, 2005, 194(1-2):1-6.
[35] KIM J Y, SONG J Y, YOON Y K, et al. Middle east respiratory syndrome infection control and prevention guideline for healthcare facilities[J]. Infect Chemother, 2015, 47(4):278-302.
[36] National Health Commission of the People's Republic of China. Prevention and control of novel coronavirus(2019-nCoV)-infected pneumonia(guidance v3). [EB/OL]. [2020-01-28]. http://www. nhc. gov. cn/xcs/zhengcwj/202001/470b128513fe46f086d79667db9f76a5. shtml
[37] National Health Commission of the People's Republic of China. Notice on optimizing the prevention and control of infection in medical institutions. [EB/OL]. [2019-05-18]. http://www. nhc. gov. cn/yzygj/s7659/201905/d831719a5ebf450f991ce47baf944829. shtml
[38] National Health Commission of the People's Republic of China. Notice on management of medical waste in medical institutions during the outbreak of human infection with novel coronavirus(2019-nCoV). [EB/OL]. [2020-01-28]. http://www. gov. cn/zhengce/zhengceku/2020-01/28/content_5472796. htm
[39] Beijing Municipal Health Commission. Guideline for medical staff on isolation and protection from infectious diseases. [EB/OL]. [2018-8-30]. http://www. beijing. gov. cn/zfxxgk/110088/qtbz23/2018-11/13/content_2c6b116bc6024e54a2aefd12d50fa0c6. shtml
[40] Beijing Pharmacy Center for Quality Control and Improvement. Recommendations for management of Novel coronavirus-infected pneumonia in pharmaceutical department of medical institutions(v2)[EB/OL]. [2020-02-06].
[41] National Health Commission of the People's Republic of China. National Essential Medicines List(2018). [EB/OL]. [2018-09-30]. http://www. nhc. gov. cn/yaozs/s7656/201810/c18533e22a3940d08d996b588d941631. shtml
[42] HOLSHUE M L, DEBOLT C, LINDQUIST S, et al. First Case of 2019 Novel Coronavirus in the United States[J]. N Engl J Med, 2020. DOI:10. 1056/NEJMoa2001191.
[43] National Health Commission of the People's Republic of China. Administration of Acceptance of Public Welfare Donations for Health-related Institutions(Interim)[J]. Chin Pract J Rural Doct(中国实用乡村医生杂志), 2015, 22(23):1-4.
[44] China Food and Drug Administration. Good Clinical Practice Pharmaceutical Products(GCP). [EB/OL]. [2003-08-06]. http://samr. sfda. gov. cn/WS01/CL0053/24473. html.
[45] Former Chinese Ministry of Health. Regulations on Pharmaceutical Affairs in Medical Institutions [EB/OL]. 2011-03-01. http://www. satcm. gov. cn/fajiansi/gongzuodongtai/2018-03-24/2269. html.